IBDEI22V ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33179,0)
 ;;=92201^^129^1683^5^^^^1
 ;;^UTILITY(U,$J,358.3,33179,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33179,1,2,0)
 ;;=2^92201
 ;;^UTILITY(U,$J,358.3,33179,1,3,0)
 ;;=3^Ext Ophthalmoscopy w/ Ret Drawing,Unilat/Bilat 
 ;;^UTILITY(U,$J,358.3,33180,0)
 ;;=92202^^129^1683^6^^^^1
 ;;^UTILITY(U,$J,358.3,33180,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33180,1,2,0)
 ;;=2^92202
 ;;^UTILITY(U,$J,358.3,33180,1,3,0)
 ;;=3^Ext Ophthalmoscopy w/ Optic Nerve/Macula Drawing
 ;;^UTILITY(U,$J,358.3,33181,0)
 ;;=99366^^129^1684^2^^^^1
 ;;^UTILITY(U,$J,358.3,33181,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33181,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,33181,1,3,0)
 ;;=3^Interdisc Team Mtg w/ Pt HC Pro,+30 min
 ;;^UTILITY(U,$J,358.3,33182,0)
 ;;=99368^^129^1684^3^^^^1
 ;;^UTILITY(U,$J,358.3,33182,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33182,1,2,0)
 ;;=2^99368
 ;;^UTILITY(U,$J,358.3,33182,1,3,0)
 ;;=3^Interdisc Team Mtg w/o Pt HC Pro,+30 min
 ;;^UTILITY(U,$J,358.3,33183,0)
 ;;=T1016^^129^1684^1^^^^1
 ;;^UTILITY(U,$J,358.3,33183,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33183,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,33183,1,3,0)
 ;;=3^Case Management,Ea 15 min
 ;;^UTILITY(U,$J,358.3,33184,0)
 ;;=99367^^129^1684^4^^^^1
 ;;^UTILITY(U,$J,358.3,33184,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33184,1,2,0)
 ;;=2^99367
 ;;^UTILITY(U,$J,358.3,33184,1,3,0)
 ;;=3^Team Conf w/o Patient by Physician
 ;;^UTILITY(U,$J,358.3,33185,0)
 ;;=S3000^^129^1685^1^^^^1
 ;;^UTILITY(U,$J,358.3,33185,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33185,1,2,0)
 ;;=2^S3000
 ;;^UTILITY(U,$J,358.3,33185,1,3,0)
 ;;=3^Dilated Diabetic Retinal Exam
 ;;^UTILITY(U,$J,358.3,33186,0)
 ;;=99354^^129^1686^1^^^^1
 ;;^UTILITY(U,$J,358.3,33186,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33186,1,2,0)
 ;;=2^99354
 ;;^UTILITY(U,$J,358.3,33186,1,3,0)
 ;;=3^Direct Pt Contace,1st hr beyond usual svc
 ;;^UTILITY(U,$J,358.3,33187,0)
 ;;=99355^^129^1686^2^^^^1
 ;;^UTILITY(U,$J,358.3,33187,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33187,1,2,0)
 ;;=2^99355
 ;;^UTILITY(U,$J,358.3,33187,1,3,0)
 ;;=3^Each Addl 30 min (in addition to 99354)
 ;;^UTILITY(U,$J,358.3,33188,0)
 ;;=4174F^^129^1687^1^^^^1
 ;;^UTILITY(U,$J,358.3,33188,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33188,1,2,0)
 ;;=2^4174F
 ;;^UTILITY(U,$J,358.3,33188,1,3,0)
 ;;=3^Couns Potential Glauc Impct
 ;;^UTILITY(U,$J,358.3,33189,0)
 ;;=4450F^^129^1687^5^^^^1
 ;;^UTILITY(U,$J,358.3,33189,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33189,1,2,0)
 ;;=2^4450F
 ;;^UTILITY(U,$J,358.3,33189,1,3,0)
 ;;=3^Self-Care Ed Provided to Pt
 ;;^UTILITY(U,$J,358.3,33190,0)
 ;;=4177F^^129^1687^6^^^^1
 ;;^UTILITY(U,$J,358.3,33190,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33190,1,2,0)
 ;;=2^4177F
 ;;^UTILITY(U,$J,358.3,33190,1,3,0)
 ;;=3^Talk Pt/Crgvr Re AREDS
 ;;^UTILITY(U,$J,358.3,33191,0)
 ;;=98960^^129^1687^4^^^^1
 ;;^UTILITY(U,$J,358.3,33191,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33191,1,2,0)
 ;;=2^98960
 ;;^UTILITY(U,$J,358.3,33191,1,3,0)
 ;;=3^Edu/Trn,Self-Mgmt,Indiv,Ea 15 min
 ;;^UTILITY(U,$J,358.3,33192,0)
 ;;=98961^^129^1687^2^^^^1
 ;;^UTILITY(U,$J,358.3,33192,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,33192,1,2,0)
 ;;=2^98961
 ;;^UTILITY(U,$J,358.3,33192,1,3,0)
 ;;=3^Edu/Trn,Self-Mgmt,2-4 Pts,Ea 15 min
 ;;^UTILITY(U,$J,358.3,33193,0)
 ;;=98962^^129^1687^3^^^^1
 ;;^UTILITY(U,$J,358.3,33193,1,0)
 ;;=^358.31IA^3^2
